Catalent | CTLT - Заемный капитал



Заемный капитал Изменить Дата
Agilent USD 3.05B 0 2025-12
AstraZeneca USD 26.14B 19.58B 2025-12
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Bruker USD 1.85B 131.7M 2025-12
Centene USD 17.35B 194M 2025-12
Charles River Laboratories USD 2.14B 49.09M 2025-12
Cigna USD 30.95B 4.47B 2025-09
Danaher USD 18.42B 1.58B 2025-12
Dentsply International USD 2.02B 2M 2025-12
Elevance Health USD 30.8B 376M 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
Glaxosmithkline GBP 19.82B 203.13M 2025-12
Hologic USD 2.5B 2.1M 2025-12
Humana USD 12.37B 238M 2025-12
Illumina USD 1.49B 496M 2025-12
Intuitive Surgical USD 0 0 2025-03
IQVIA Holdings USD 13.88B 1.09B 2025-12
J&J USD 39.44B 30M 2025-12
Laboratory Of America USD 5.15B 800K 2025-12
Lonza CHF 3.88B 323M 2025-12
McKesson USD 5.43B 586M 2025-12
Merck EUR 10.73B 277M 2025-12
Merck USD 39.97B 6B 2025-09
Mettler Toledo International USD 2.09B 58.01M 2025-12
Novartis USD 29.59B 5.35B 2025-12
Pfizer USD 57.41B 93M 2025-09
Quest Diagnostics USD 5.17B 4M 2025-12
Repligen USD 542.21M 4.29M 2025-12
Revvity USD 2.63B 543K 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Thermo Fisher Scientific USD 35.85B 4B 2025-12
UnitedHealth USD 72.32B 79M 2025-12
Veradigm USD 200.4M 69K 2022-12
Waters USD 1.41B 460.24M 2025-12
West Pharmaceutical Services USD 202.8M 100K 2025-12